Background: Although recombinant adenovirus vectors are attractive for use in gene expression studies and therapeutic applications, the construction of these vectors remains relatively time-consumning. We report here a strategy that simplifies the production of adenoviruses using the Cre-loxP system. Materials and Methods: Full-length recombinant adenovirus DNA was generated in vitro by Cre-mediated recombination between loxP sites in a linearized shuttle
Introduction
A major barrier to the application of adenoviral vector technology is the time-consuming procedure of making recombinant viruses. In general, two approaches have been used to generate recombinant adenoviruses. The first is the direct ligation of the adenoviral genome to DNA fragments containing the gene of interest (1) (2) (3) . Because of the low efficiency of large fragment ligations, it is difficult to obtain a sufficient amount of ligated DNA for transfection into helper cells. A second, more widely used method involves homologous recombination in mammalian helper cells between a shuttle plasmid corresponding to the left end of the recombinant and overlapping DNA of virus origin that has been rendered noninfectious (4) (5) (6) . This approach has facilitated the construction of recombinant adenoviral vectors; however, since homologous recombination is a rare event in mammalian cells, these procedures are often unpredictable, time-consuming, and difficult to control. To circumvent these problems of efficiency and contamination of wild-type adenoviMolecular Medicine © 1999 The Picower Institute Press 225 rus, we proposed using Cre-loxP recombination in vitro.
The Cre-loxP recombination system of bacteriophage P1 catalyzes site-specific recombination in vitro (7, 8) , in eukaryotic cells (9) (10) (11) , and in transgenic animals (12, 13) . Only two components are required to mediate recombination: the 38-kD Cre recombinase and the 34-bp loxP site (14) (15) (16) (17) . The loxP site consists of two 13-bp inverted repeats flanking an asymmetric 8-bp spacer (15) . Cre can mediate inter-or intramolecular recombination upon recognition of two loxP sites on either linear or supercoiled DNA. Recombination between two directly repeated sites on the same DNA molecules excises the DNA segment lying between the sites (7, 18) . If the loxP sites are present on separate linear molecules, recombinase action results in the mutual exchange of regions distal to the sites (18, 19) . Using the Cre-loxP reaction, we prepared fulllength recombinant adenoviral DNA in vitro by recombination between a shuttle plasmid and adenovirus genomic DNA that was previously truncated near the left end. Homogeneous viral vectors were effectively obtained 7-9 days after transfecting the recombined DNA into 293 cells. This study shows that recombinant adenoviral DNA can be constructed in vitro using the CreloxP system, which results in highly efficient viral production and decreases the time required to generate adenoviral vectors.
Materials and Methods

Shuttle Plasmids and Recombinant Adenovirus Cosmid
In the pAdMCS plasmid, a multiple cloning site was inserted into the Bglll site of pAd-BqlI (20) 25 ,ul of lipofectAMINE (Gibco-BRL) to 400 ,ul of Opti-MEM. After incubation at room temperature for 45 min, 1.6 ml of OptiMEM was added to the transfection mix, and the DNA/lipid complex was added to the cells. After 4-5 hr at 370C, the transfection mix was removed and 3 ml of growth media were added. Transfected cells were observed daily. After 7 to 9 days, when they showed a cytopathic effect, cells were harvested, then centrifuged at 220 X g for 5 min. The medium was removed and 500,l of 10 mM Tris-Cl, pH 8 .0 was added. After four cycles of freezing in ethanol/dry ice and rapid thawing at 370C, viral lysate was spun at 2500 X g for 7 min and adenovirus-containing supernatant was collected. At this point, the viral titers were often high enough to use for gene-transfer experiments in cultured cells. To generate higher titer viral stocks, 293 cells were infected at a multiplicity of infection (MOI) of 0.1 to 1 and grown for 2-3 days, at which time viruses were harvested as described above. This process was repeated 1-2 times, with a final round using 2 X 108 cells in fifteen 15- 3-galactosidase ((3-Gal) staining was used to determine the expression of (3-Gal from the recombinant adenovirus. Briefly, the infected cells were fixed for 10 min at room temperature in phosphate-buffered saline (PBS) buffer with 0.25% glutaraldehyde. After washing with PBS, the fixed cells were stained using 1 mg/ml of X-gal (Gibco-BRL) in 5 mM potassium ferricyanide, with 2 mM potassium ferrocynaide and 2 mM magnesium sulfate.
Results
Strategy to Make Adenovirus Using Cre-loxP System
In Vitro A shuttle plasmid was constructed that contained the adenoviral 5' -ITR and a packaging signal from 0 to 1 mu, the transgene of interest, and a single loxP sequence 3' of the transgene and 9.2-16.1 mu (Fig. IA ). An adenoviral cosmid was also generated to include 9.2-100 mu of the adenovirus genome, a deletion in the E3 region and a loxP site at 9.2 mu. The shuttle plasmid is linearized at the left end of the viral genome, and the adenoviral cosmid is digested at the left and right end of the viral genome. Cre recombinase produces the full-length recombinant adenoviral vector in vitro by intermolecular recombination between the loxP sites in these two linearized molecules. It is not necessary to remove the unrecombined DNA, because only recombined adenoviral DNA among the four molecules in the Cre reaction mixture can give rise to adenovirus. The Cre-treated DNA is transfected into adenoviral helper cell lines such as 293 cells, and recombinant adenovirus can then be produced.
Recombination Efficiency In Vitro by Cre Recombinase
The NheI-digested left-end plasmid, pAdCMVlacZloxP, and the ClaI-digested right-end cosmid, cS3601oxP, were incubated with Cre recombinase in vitro. To confirm recombination, 500 ng A. (Fig. 2C ).
Time Course of Viral Production
To determine the time course of viral production, cells were collected at various times after transfection, and crude cell lysates were assessed for viral production using the f-galactosidase (lacZ) reporter. Controls, digested pAdCMVlacZloxP alone, cS360loxP alone, or pAdCMVlacZloxP and cS360loxP incubated in the absence of Cre were analyzed. Significant amounts of lacZ adenovirus were detected with Cre-treated DNA as early as 5 days after transfection, and the levels substantially increased over time. Viral titers after [7] [8] [9] days ranged from 106 to 109/ml as demonstrated by lacZ staining. When this Cre-treated day 9 lysate was used to infect 1 X 106 293 cells, titers of 1010 to 10"/ml were observed 2 days later (Figs. 3 and 4A ). These viruses could infect a variety of cell lines of human, pig, and mouse origin. For example, PASMC showed more than 90% transduction (Fig. 4B) . A smaller, yet readily detectable, quantity of vector was generated after cotransfection of digested pAdCMVlacZloxP and cS360loxP incubated in vitro in the absence of Cre (Fig. 3 ). Viral titers after 7-9 days ranged from 0 to 103/ml; and when day 9 vivo homologous recombination method is the frequent contamination of initial lysates with replication-competent adenoviruses. Our recombinant adenoviral cosmid lacks the adenoviral 5'-ITR and packaging signal, eliminating the possibility of contamination of wild-type adenovirus through incomplete enzyme digestion. The lack of detectable genome heterogeneity in the viral preparation as shown by Southern blot analysis (Fig. 2) indicates that plaque purification is not necessarily required in experiments, and screening of a small number of plaques is enough to identify clones which can be used for further experimental or clinical studies. We have generated more than 15 different adenoviruses with the system described here. Indeed, the different viral preparations were always found to be homogeneous by restriction and Southern blot analysis. Furthermore, we analyzed the contamination of replication-competent viruses in 11 different large-scaled recombinant viruses by TaqMan PCR method (Perkin-Elmer), which is very sensitive and quantitative. Titers of replicationcompetent viruses ranged from 0 to 5 x 104 particle/ml in 1 X 1012 particle/ml of recombinant viruses, which was much less than that of plaque-purified viruses through the conventional in vivo homologous recombination method (data not shown).
There are some reports describing the generation of recombinant viruses through homologous recombination in a yeast or bacteria (23) (24) (25) (26) or direct ligation using cosmids (27) . These methodologies represent a significant improvement over conventional recombinant adenoviral construction technology. The Cre-loxP system reported here, however, is more rapid and convenient than these protocols, because colony screening is not necessary. An important feature of Cre-generated recombinants is that they result from a well-characterized, site-specific in vitro recombination event and not from poorly understood recombination processes in cells that can result in accompanying DNA rearrangements. Indeed, all five different adenoviral vectors that we sequenced across the recombination joints showed precise recombination. The ability to recover reasonable quantities of homogeneous viruses over a short time represents a major practical advantage, and can facilitate the development of adenoviral vectors for a variety of purposes.
